ACCESSION: MSBNK-SMB_Measured-HSA001P0260001
RECORD_TITLE: Characterized; Hexanoylcarnitine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 19
COMMENT: RAW_SPEC {'19_posi_2681': {'bp': 238126.0, 'sum': 410075.0}, '5_posi_2680': {'bp': 228881.0, 'sum': 457939.0}, '16_posi_2534': {'bp': 223967.0, 'sum': 405847.0}, '14_posi_2496': {'bp': 221297.0, 'sum': 388803.0}, '9_posi_2533': {'bp': 220242.0, 'sum': 418326.0}, '4_posi_2515': {'bp': 217895.0, 'sum': 389162.0}, '5_posi_2470': {'bp': 207254.0, 'sum': 376059.0}, '17_posi_2579': {'bp': 190709.0, 'sum': 345061.0}, '3_posi_2492': {'bp': 190671.0, 'sum': 389943.0}, '12_posi_2533': {'bp': 187651.0, 'sum': 345007.0}, '8_posi_2720': {'bp': 184345.0, 'sum': 386531.0}, '6_posi_2539': {'bp': 180100.0, 'sum': 348466.0}, '11_posi_2556': {'bp': 178285.0, 'sum': 372728.0}, '8_posi_2494': {'bp': 159062.0, 'sum': 320364.0}, '14_posi_2580': {'bp': 156258.0, 'sum': 310949.0}, '1_posi_2471': {'bp': 153246.0, 'sum': 316288.0}, '5_posi_2555': {'bp': 138598.0, 'sum': 266624.0}, '15_posi_2538': {'bp': 129655.0, 'sum': 263249.0}, '8_posi_2574': {'bp': 128523.0, 'sum': 260988.0}}
COMMENT: RETENTION_TIME_STDEV 0.141
COMMENT: PRECURSOR_M/Z_RAW 260.185128
COMMENT: PRECURSOR_M/Z_STDEV 0.000105
COMMENT: PRECURSOR_IN_MS1 mz 260.185659; int 2.147; delta(ppm) 1.386618
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.096; C13H25NO4; [M+H]+; delta(ppm) 0.096459
COMMENT: PROPOSED_MF MS-FINDER 3.274; C13H25NO4; [M+H]+; delta(ppm) 0.093300
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.988; C13H25NO4; [M+H]+; delta(ppm) 0.093300
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.917; C14H21N5; [M+H]+; delta(ppm) -5.046904
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.983; C13H25NO4; [M+H]+; delta(ppm) 0.093300
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.017; C14H21N5; [M+H]+; delta(ppm) -5.046904
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.016; C13H25NO4; [M+H]+; delta(ppm) 0.093300
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.168; C14H21N5; [M+H]+; delta(ppm) -5.046904
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.219; C11H23N4O3; [M+H]+; delta(ppm) 5.253733
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.597; C11H22FN5O; [M+H]+; delta(ppm) -9.438528
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.705; C16H23N2O; [M+H]+; delta(ppm) -10.207232
COMMENT: PROPOSED_MF SIRIUS6_Sirius -9.124; C10H24N6P; [M+H]+; delta(ppm) -6.234901
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C13H25NO4; [M+H]+; delta(ppm) 0.093300
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C14H21N5; [M+H]+; delta(ppm) -5.046904
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; VVPRQWTYSNDTEA-LLVKDONJSA-N; C13H25NO4; Massbank:RP025501 Hexanoyl-L-CarnitineL-Hexanoylcarnitine(3R)-3-hexanoyloxy-4-(trimethylazaniumyl)butanoate
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; VVPRQWTYSNDTEA-UHFFFAOYSA-N; C13H25NO4; C6Hexanoyl-L-Carnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.942; VVPRQWTYSNDTEA-UHFFFAOYNA-N; [M+H]+; Hexanoylcarnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.219; MZWSBOAUAGJSFQ-UHFFFAOYSA-N; [M+H]+; 6-(2-methoxyethoxy)-4-(oxan-4-yl)-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.075; QLFLCFNDXBHOFL-UHFFFAOYSA-N; [M+H]+; N-[2,3-dihydroxy-4-(methoxymethyl)cyclopentyl]-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.031; NTUGPDFKMVHCCJ-UHFFFAOYSA-N; [M+H]+; 1,5-di-tert-butyl 2-aminopentanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VVPRQWTYSNDTEA-UHFFFAOYNA-N; [M+H]+; Hexanoylcarnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.153; NTUGPDFKMVHCCJ-UHFFFAOYSA-N; [M+H]+; 1,5-di-tert-butyl 2-aminopentanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.106; QLFLCFNDXBHOFL-UHFFFAOYSA-N; [M+H]+; N-[2,3-dihydroxy-4-(methoxymethyl)cyclopentyl]-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.106; MZWSBOAUAGJSFQ-UHFFFAOYSA-N; [M+H]+; 6-(2-methoxyethoxy)-4-(oxan-4-yl)-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; NTUGPDFKMVHCCJ-VIFPVBQESA-N; [M+H]+; ditert-butyl (2S)-2-aminopentanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.466; MOMGPXHNANHSBY-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(hydroxymethyl)-4-(methoxymethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.424; FPRZYWCRQHFPSX-UHFFFAOYSA-N; [M+H]+; 8-[(2-methylpropan-2-yl)oxycarbonylamino]octanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.410; AMAFOMIBEAFCPF-UHFFFAOYSA-N; [M+H]+; 6-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]heptanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.377; PYBXMFXUNZVYRB-JTQLQIEISA-N; [M+H]+; (3S)-5-methyl-3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.377; CJERADZJMWHFHH-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-(2-hydroxyethoxymethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.372; JEPJZGUFARGBJH-SNVBAGLBSA-N; [M+H]+; tert-butyl (4R)-4-(3-hydroxypropyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.364; GNXVWBCBVJMWHV-UHFFFAOYSA-N; [M+H]+; 4,4-dimethyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -4.542; VVPRQWTYSNDTEA; [M+H]+; Tocris-0526
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.953; SSTNIYGGKUSZKC; [M+H]+; 1-tert-Butyl-2-cyano-3-(2,4,6-trimethyl-3-pyridyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.693; ZKULTGLIOSGMEG; [M+H]+; 1-cyano-2-(2,4-dimethylpentan-3-yl)-3-pyridin-4-ylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.618; HGMSOOASNOMSJR; [M+H]+; 1-cyano-2-(2,4-dimethylpentan-3-yl)-3-pyridin-3-ylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.959; YQCMJXODNUFPHT; [M+H]+; 2-Cyano-1-heptyl-3-(3-pyridyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.281; XLLCSECCUBEZSF; [M+H]+; 2-Cyano-1-(4-pyridyl)-3-(1,1,3-trimethylbutyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.207; SFKWTCJAGVWNSL; [M+H]+; 2-Cyano-1-(3-pyridyl)-3-(1,1,3-trimethylbutyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.220; ZQUFJXPVWXIVIH; [M+H]+; 2-Cyano-1-(1,1-diethylpropyl)-3-(4-pyridyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.073; UZBRBIURPVXZTM; [M+H]+; 1-cyano-3-pyridin-4-yl-2-(2,3,3-trimethylbutan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.146; DUHKVGCSEPEJRY; [M+H]+; 1-cyano-2-(3-ethylpentan-3-yl)-3-pyridin-3-ylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.998; URAOWGRHICKCQA; [M+H]+; 1-cyano-3-pyridin-3-yl-2-(2,3,3-trimethylbutan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.593; NTUGPDFKMVHCCJ; [M+H]+; ACMC-20lwoq
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.781; YHIMFWJZBVHIPZ; [M+H]+; diethyl 2-aminononanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -374.340; KMJKCCBUNDCOGC; [M+H]+; 2-tert-butyl-1-cyano-3-(4-dimethylaminophenyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -416.599; MZWSBOAUAGJSFQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -446.991; OXOGEAMCKQTZJP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -524.103; QLFLCFNDXBHOFL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -612.178; PETSRUBXPDOLKZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.983; VVPRQWTYSNDTEA; [M+H]+; Tocris-0526
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -85.814; HPKZJKWIYUYEKQ; [M+H]+; 3-Methylpentanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -91.702; VVPRQWTYSNDTEA; [M+H]+; 2,2,3-Trideuterio-3-hexanoyloxy-4-(trimethylazaniumyl)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -151.554; GCKJJXWIYAKHOA; [M+H]+; 4-Methylpentanoylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -323.646; PYBXMFXUNZVYRB; [M+H]+; (S)-3-(((tert-Butoxycarbonyl)amino)methyl)-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -402.363; NTUGPDFKMVHCCJ; [M+H]+; 1,5-di-tert-butyl 2-aminopentanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -435.521; FPRZYWCRQHFPSX; [M+H]+; 8-[(2-Methylpropan-2-yl)oxycarbonylamino]octanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -444.758; MZWSBOAUAGJSFQ; [M+H]+; 6-(2-methoxyethoxy)-4-(oxan-4-yl)-1,4-oxazepane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -468.314; YHIMFWJZBVHIPZ; [M+H]+; diethyl (2S)-2-aminononanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -520.234; OXOGEAMCKQTZJP; [M+H]+; N-(2-Hydroxyoctyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -683.595; QLFLCFNDXBHOFL; [M+H]+; N-[2,3-dihydroxy-4-(methoxymethyl)cyclopentyl]-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.568; HPKZJKWIYUYEKQ; [M+H]+; 3-Methylpentanoylcarnitine
COMMENT: CONFIDENCE Level 3: Tentative candidate, Hexanoylcarnitine, VVPRQWTYSNDTEA-UHFFFAOYNA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1); This structural isomer was suggested from the biological context HMDB HMDB0000705;HMDB0000756;
CH$NAME: Hexanoylcarnitine
CH$NAME: (3-carboxy-2-hexanoyloxypropyl)-trimethylazanium
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C13H26NO4+
CH$EXACT_MASS: 260.186183
CH$SMILES: CCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C
CH$IUPAC: InChI=1S/C13H25NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h11H,5-10H2,1-4H3/p+1
CH$LINK: CHEBI CHEBI:70749
CH$LINK: HMDB HMDB0000705
CH$LINK: INCHIKEY VVPRQWTYSNDTEA-UHFFFAOYSA-O
CH$LINK: LIPIDMAPS LMFA07070001
CH$LINK: PUBCHEM CID:3082079
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.121
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 260.185659
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1090000000-a2bd15d329e1ff5dcc74
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  60.0807578 36.4075 60.081397 1.3482 7.74 0.5934 18 f{C3H10N1}/-0.30ppm,p-C10H17O4
  85.0284123 189.7026 85.028892 0.8115 22.07 0.8105 19 f{C4H5O2}/0.08ppm,p-C9H22N1O2
  201.1122241 138.3496 201.112089 1.8547 20.28 0.7877 19 f{C10H17O4}/0.44ppm,p-C3H10N1
  242.1613632 59.3838 242.161203 3.9726 21.71 -0.0392 17 ?
  242.1974266 141.2286 242.197267 2.2089 34.38 0.2316 19 ?
  243.1591747 81.5518 243.159014 2.4099 26.17 -0.2466 18 f{C13H23O4}/0.37ppm,p-H4N1
  260.1857947 999.0000 260.185624 0.5996 0.00 1.0000 19 f{C13H26N1O4}/0.61ppm,p-H1
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  60.080758 36.41 36
  85.028412 189.70 189
  201.112224 138.35 138
  242.161363 59.38 59
  242.197427 141.23 141
  243.159175 81.55 81
  260.185795 999.00 999
//
